Tweet Archive for May 2016 « page 2
#ASCO16 and #skincancer #cancerawareness
Skin cancer: pembrolizumab gives '40% melanoma survival' #ImmunoOnc #ASCO16 https://t.co/Z1B6F4wfB8
— Miguel Perales M.D. (@DrMiguelPerales) May 19, 2016
#ASCO16 and #skincancer #cancerawareness
Read the #Keytruda #pembrolizumab #ASCO16 results now on #medipaper #ImmuneCheckPoint #melanoma #nsclc #skincancerhttps://t.co/zvU3tthBPP
— MEDIPAPER | 醫學作家香港 (@MediPaper) May 20, 2016
#ASCO16 and #skincancer #cancerawareness
#Keytruda having impressive data at #ASCO16 in #Melanoma. Data here: https://t.co/KtaC1Fhubh#skincancer #asco2016
— MEDIPAPER | 醫學作家香港 (@MediPaper) May 20, 2016
#ASCO16 and #skincancer #cancerawareness
Merck and Pfizer will be sharing new data in #MerkelCellCarcinoma on June 6 at #ASCO16 #AdvanceIO #SkinCancer
— Merck (@merckgroup) May 30, 2016
RT @drkarenhorton: 12 Sunscreens Are Lying About SPF grt.st/1XCQEc2 via @Greatist @HortonSPA recommends PHYSICAL sunblocks with ti…
RT @CebdNottm: If evidence dissemination on twitter attracts new follows (esp general public) – that has to be a good thing! @OlivierBranfo…
RT @marthasheasmith: #plasticsurgery hashtag also serves to educate patients, those who love them and the general public🌷 https://t.co/iCgs…
RT @OlivierBranford: Board certified plastic surgeons should use the hashtag #PlasticSurgery @einsteinmedi einsteinmedical.com/blog/2016/03/1… https://…
RT @DerekCStewart: Open access? gu.com/p/4jzz8?CMP=Sh…
RT @BrJDermatol: The May issue of the BJD is now online, the table of contents can be found here: goo.gl/5N3y2P #BJD